Major adverse kidney events
Showing 1 - 25 of >10,000
Acute Kidney Injury, Septic Shock, Nicotinamide Trial in Amiens (Nicotinamide treatment, treatment)
Recruiting
- Acute Kidney Injury
- +3 more
- Nicotinamide treatment
- placebo treatment
-
Amiens, FranceCHU Amiens
Dec 8, 2022
Novel Cardiovascular Biomarkers in Patients With Kidney Disease
Not yet recruiting
- Haemodialysis Complication
- Major Adverse Cardiac Events
- Cardiac Biomarkers
- +2 more
- (no location specified)
Sep 14, 2023
Inclisiran on Major Adverse Cardiovascular Events in French
Not yet recruiting
- Atherosclerotic Cardiovascular Disease
- Inclisiran sodium
- +3 more
- (no location specified)
Jul 26, 2023
Diabetes, Type 2, Major Adverse Cardiac Events Trial in Hangzhou (CGM)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Major Adverse Cardiac Events
- CGM
-
Hangzhou, Chinathe Second Affiliated Hospital Zhejiang University Schoolof Medi
Sep 23, 2023
Major Adverse Cardiovascular Events in Coronary Artery Disease
Completed
- Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease
-
Jinan, Shandong, ChinaYuguo Chen
Sep 20, 2022
Obesity Trial (Naltrexone-Bupropion (NB) Combination, Placebo)
Not yet recruiting
- Obesity
- Naltrexone-Bupropion (NB) Combination
- Placebo
- (no location specified)
Oct 18, 2023
Anticoagulant Drug Intervention on Postoperative MALE and MACE
Recruiting
- Anticoagulant Drugs
- +2 more
- anticoagulant or antiplatelet drugs
-
Hangzhou, None Selected, ChinaFirst Affiliated Hospital of Zhejiang University
May 8, 2023
Arteriosclerosis, Hypercholesterolaemia Trial (MK-0616, Placebo)
Not yet recruiting
- Arteriosclerosis
- Hypercholesterolaemia
- MK-0616
- Placebo
- (no location specified)
Aug 17, 2023
Adverse Events in Acute Limb Ischemic Patient Undergoing
Recruiting
- Major Adverse Cardiac Events
- Adverse Effect of Unspecified General Anesthetic
-
Bangkok, Thailand
- +1 more
May 3, 2022
Cardiovascular Primary Prevention Strategy Trial in Murray (Coronary Artery Calcium Screening and Statin Treatment, Standard
Recruiting
- Cardiovascular Primary Prevention Strategy
- Coronary Artery Calcium Screening and Statin Treatment
- Standard Treatment
-
Murray, UtahIntermountain Medical Center and Intermountain Clinics
Aug 8, 2022
Primary Prevention of Atherosclerotic Cardiovascular Disease Trial (Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran)
Not yet recruiting
- Primary Prevention of Atherosclerotic Cardiovascular Disease
- Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL
- Placebo in 1.5ml
- (no location specified)
Feb 13, 2023
Patient Acceptance of Health Care, Acute Renal Failure Trial (Clinical decision support, Will not receive Clinical Decision
Not yet recruiting
- Patient Acceptance of Health Care
- Acute Renal Failure
- Clinical decision support
- Will not receive Clinical Decision Support
- (no location specified)
Jun 26, 2023
Coronary Artery Disease Trial in United States (Colchicine, Placebo)
Not yet recruiting
- Coronary Artery Disease
- Colchicine
- Placebo
-
Long Beach, California
- +4 more
Nov 15, 2022
GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Type 2
Recruiting
- Diabetes Mellitus, Type 2
- Myocardial Infarction
- PCI
-
Naples, ItalyCelestino Sardu
Aug 31, 2023
Coronary Artery Disease Progression Trial (Intensive lipid-lowering control, Moderate-intensity lipid-lowering control)
Not yet recruiting
- Coronary Artery Disease Progression
- Intensive lipid-lowering control
- Moderate-intensity lipid-lowering control
- (no location specified)
Jul 13, 2022
Atrial Fibrillation, Anticoagulant Adverse Reaction, Stroke Trial (low-dose rivaroxaban, Standard-dose rivaroxaban)
Not yet recruiting
- Atrial Fibrillation
- +3 more
- low-dose rivaroxaban
- Standard-dose rivaroxaban
- (no location specified)
Oct 25, 2023
Chronic Kidney Disease, CKD, Cardiac Disease Trial in Worldwide (Placebo, Ravulizumab)
Not yet recruiting
- Chronic Kidney Disease
- +3 more
- Placebo
- Ravulizumab
-
San Francisco, California
- +96 more
Feb 27, 2023
CT-based Myocardial Characterization (CTMyoC)
Recruiting
- Different Cardiomyopathy and Major Cardiovascular Adverse Events
-
Milano, ItalyIRCCS San Raffaele
Sep 1, 2023
Vascular Events In Patients Undergoing Same-day Noncardiac
Recruiting
- Preoperative Care
- +2 more
-
Montreal, Quebec, Canada
- +1 more
Jul 28, 2022
Cardiovascular Diseases Trial in Peking (cardiovascular magnetic resonance (CMR))
Completed
- Cardiovascular Diseases
- cardiovascular magnetic resonance (CMR)
-
Peking, Beijing, ChinaChinese PLA General Hospital
Apr 3, 2022
Major Adverse Cardiovascular Events for Naldemedine and Other
Recruiting
- Opioid-induced Constipation
- Naldemedine
- +2 more
-
Wilmington, DelawareResearch Site
Feb 28, 2022
Obstructive Hypertrophic Cardiomyopathy
Completed
- Microvascular Dysfunction
- +2 more
-
Beijing, Beijing, ChinaFuwai Hospital, China National Center for Cardiovascular Disease
Jan 11, 2023
Peripheral Arterial Disease Trial in Fribourg, Zurich (sirolimus-coated balloon catheter, uncoated balloon catheter)
Recruiting
- Peripheral Arterial Disease
- sirolimus-coated balloon catheter
- uncoated balloon catheter
-
Fribourg, Switzerland
- +1 more
Mar 4, 2022
Blood and Urine Kidney Injury Markers to Facilitate Early
Recruiting
- Kidney Impairment
- blood test for renal biomarkers
- urine test for renal biomarkers
-
Basel, SwitzerlandUniversity Children's Hospital Basel (UKBB), University of Basel
Mar 1, 2022
Effect of CVP and IOH on AKI and AKD
Completed
- Acute Kidney Injury
- Acute Kidney Disease
- Venous congestion
- Introperation hypotension
-
Nanjing, Jiangsu, ChinaNanjing First Hospital
Jan 23, 2022